Discount per Quantity Orders over $200 receive: FREE - USPS priority shipping Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Peptide Blend Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin peptide blend is a combination of peptides that may potentially interact with receptors in the pituitary gland
People who use Zepbound or Mounjaro, the dual-agonist medications, lose an average of about 20% of their body weight, while those who take Ozempic or Wegovy, the single-agonist drugs, lost an average of about 14% of their body weight
Two primary reasons: First, immunogenicity
For broader context on evaluating research peptide suppliers, our guide to choosing a research peptide supplier covers the full vetting framework
They come in several sizes: 0.3 mL (30 units), 0.5 mL (50 units), and 1 mL (100 units)